Wells Fargo’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-67,477
Closed -$22M – 7677
2024
Q1
$22M Buy
67,477
+10,175
+18% +$2.5M 0.01% 1177
2023
Q4
$10.9M Sell
57,302
-5,848
-9% -$1.11M ﹤0.01% 1635
2023
Q3
$12.6M Sell
63,150
-6,207
-9% -$1.47M ﹤0.01% 1397
2023
Q2
$19.8M Sell
69,357
-16,220
-19% -$4.5M 0.01% 1141
2023
Q1
$18.6M Buy
85,577
+6,769
+9% +$1.32M 0.01% 1179
2022
Q4
$16.2M Buy
78,808
+1,885
+2% +$477K ﹤0.01% 1237
2022
Q3
$21.4M Sell
76,923
-6,763
-8% -$1.72M 0.01% 1033
2022
Q2
$16M Sell
83,686
-180,042
-68% -$31.8M ﹤0.01% 1267
2022
Q1
$54.7M Sell
263,728
-2,343
-0.9% -$386K 0.01% 735
2021
Q4
$47.4M Sell
266,071
-941,716
-78% -$186M 0.01% 798
2021
Q3
$249M Buy
1,207,787
+19,146
+2% +$3.76M 0.05% 340
2021
Q2
$226M Sell
1,188,641
-248,856
-17% -$40.7M 0.05% 368
2021
Q1
$187M Sell
1,437,497
-78,366
-5% -$9.4M 0.04% 415
2020
Q4
$157M Buy
1,515,863
+53,673
+4% +$4.65M 0.04% 462
2020
Q3
$111M Buy
1,462,190
+64,500
+5% +$3.66M 0.03% 516
2020
Q2
$66.2M Buy
1,397,690
+254,347
+22% +$10.5M 0.02% 725
2020
Q1
$37.9M Buy
1,143,343
+847,901
+287% +$33.7M 0.01% 906
2019
Q4
$13M Buy
295,442
+3,710
+1% +$137K ﹤0.01% 1764
2019
Q3
$8.73M Buy
291,732
+181,422
+164% +$7.7M ﹤0.01% 2044
2019
Q2
$6.3M Buy
110,310
+18,890
+21% +$917K ﹤0.01% 2365
2019
Q1
$3.06M Buy
+91,420
New +$3.04M ﹤0.01% 3008

Other funds holding SWAV

Wells Fargo's SWAV Position: Q2 2024 in Review

Wells Fargo sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 67,477 shares — an estimated $22M sold.

Wells Fargo first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $249M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Wells Fargo reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 67,477 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $22M.
  • Wells Fargo first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Wells Fargo's Shockwave Medical, Inc. Common Stock position peaked at $249M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.